Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 May;43(5):588–597. doi: 10.1038/bjc.1981.88

Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.

W Hoffmann, W Werner, R Steiner, R Kaufmann
PMCID: PMC2010692  PMID: 6166306

Abstract

Lymphocytes from 278 gynaecological patients (100 controls and 178 patients with a malignant condition) have been investigated for their response to encephalitogenic factor, cancer basic protein, and KCl extract of adenocarcinoma of the body of the uterus as "antigens", using tanned sheep erythrocytes ETS as indicator particles in the electrophoretic mobility test (EMT). Electrophoretic mobility was measured with a Zeiss cytopherometer. The study was split into three test series producing in the cancer group 66% correct positive test results (34% false negatives) and in the control group 83% correct negative results (17% false positives). Consequently, with the instrumentation used, EMT is, at least in our hands, not sufficiently reliable for the diagnosis of cancer.

Full text

PDF
588

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvilommi H., Dale M. M., Desai H. N., Mongar J. L., Richardson M. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer. Br J Cancer. 1977 Nov;36(5):545–549. doi: 10.1038/bjc.1977.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bagshawe K. D. Macrophage electrophoretic mobility and structuredness of cytoplasmic matrix. Antibiot Chemother (1971) 1978;22:155–160. doi: 10.1159/000401161. [DOI] [PubMed] [Google Scholar]
  3. Bögelspacher H. R., Tautz C., Geppert M. Der Elektrophorese-Mobilitäts-(EM-)Test bei präinvasiven dysplastischen Epithelveränderungen an der Portio vaginalis uteri. Geburtshilfe Frauenheilkd. 1980 Jun;40(6):545–549. doi: 10.1055/s-2008-1037373. [DOI] [PubMed] [Google Scholar]
  4. Carnegie P. R., Caspary E. A., Field E. J. Isolation of an "antigen" from malignant tumours. Br J Cancer Suppl. 1973 Aug;1:219–223. [PMC free article] [PubMed] [Google Scholar]
  5. Caspary E. A., Field E. J. Sensitization of blood lymphocytes to possible antigens in neurological disease. Eur Neurol. 1970;4(5):257–266. doi: 10.1159/000114027. [DOI] [PubMed] [Google Scholar]
  6. Chiu B., Hause L., Rothwell D., Koethe S., Straumfjord J. Effects of encephalitogenic factor on lymphocytic electrophoretic mobility for cancer patients and controls. Br J Cancer. 1977 Aug;36(2):288–290. doi: 10.1038/bjc.1977.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crozier E. H., Hollinger M. E., Woodend B. E., Robertson J. H. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis. J Clin Pathol. 1976 Jul;29(7):608–609. doi: 10.1136/jcp.29.7.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dickinson J. P., Caspary E. A., Field E. J. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer. 1973 Feb;27(2):99–105. doi: 10.1038/bjc.1973.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Douwes F. R., Spellmann H. J., Mross K., Wolfrum D. I. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma. Oncology. 1978;35(4):163–167. doi: 10.1159/000225277. [DOI] [PubMed] [Google Scholar]
  10. Dyson J. E., Corbett P. J. Effect of lymphocyte supernatants on the electrophoretic mobility of erythrocytes: significance in cancer diagnosis. Br J Cancer. 1978 Sep;38(3):401–410. doi: 10.1038/bjc.1978.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
  12. Field E. J., Caspary E. A. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer. 1972 Jun;26(3):164–173. doi: 10.1038/bjc.1972.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Field E. J., Caspary E. A., Smith K. S. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl. 1973 Aug;1:208–214. [PMC free article] [PubMed] [Google Scholar]
  14. Field E. J. The immunological diagnosis of human malignant disease. Ann Clin Biochem. 1976 Sep;13(5):495–502. doi: 10.1177/000456327601300147. [DOI] [PubMed] [Google Scholar]
  15. Goldstone A. H., Kerr L., Irvine W. J. The macrophage electrophoretic migration test in cancer. Clin Exp Immunol. 1973 Jul;14(3):469–472. [PMC free article] [PubMed] [Google Scholar]
  16. Günther M., Friedrich A., Erdmann T., Jenssen H. L., Werner H., Seyfarth M., Köhler H. A contribution to immunological tumour diagnostics in urology. Int Urol Nephrol. 1978;10(2):111–115. doi: 10.1007/BF02082130. [DOI] [PubMed] [Google Scholar]
  17. Harlos J. P., Weiss L. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer. Int J Cancer. 1978 Apr 15;21(4):413–417. doi: 10.1002/ijc.2910210403. [DOI] [PubMed] [Google Scholar]
  18. Jenssen R., Jenssen H. L., Köhler H., Friemel H. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases. Mod Probl Ophthalmol. 1976;16:259–264. [PubMed] [Google Scholar]
  19. Klausch B., Straube W., Hofmann R., Büttner H. H., Jenssen H. L., Köhler H., Günther J. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report. Ann Chir Gynaecol. 1977;66(4):209–213. [PubMed] [Google Scholar]
  20. Kreienberg R., Schütz G., Melchert F., Lemmel E. M. Der Elektrophorese-Mobilitäts-Hemmtest (EMT) zur immunologischen Frühdiagnostik gynäkologischer Malignome. Geburtshilfe Frauenheilkd. 1979 Aug;39(8):709–715. [PubMed] [Google Scholar]
  21. Lampert F., Nitzschke U., Zwergel T. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test. Br J Cancer. 1977 Jun;35(6):844–849. doi: 10.1038/bjc.1977.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lewkonia R. M., Kerr E. J., Irvine W. J. Clinical evaluation of the macrophage electrophoretic mobility test for cancer. Br J Cancer. 1974 Dec;30(6):532–537. doi: 10.1038/bjc.1974.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Meltzer M. S., Leonard E. J., Rapp H. J., Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971 Sep;47(3):703–709. [PubMed] [Google Scholar]
  24. Meyer-Rienecker H., Jenssen H. L., Köhler H., Günther J. K. Zur Bedeutung des Makrophagen-Elektrophorese-Mobilitätstests für die Diagnostik der Geschwülste des Zentralnervensystems. Dtsch Med Wochenschr. 1975 Mar 14;100(11):538–543. doi: 10.1055/s-0028-1106252. [DOI] [PubMed] [Google Scholar]
  25. Müller M., Irmscher J., Fischer R., Heidl G., Grossmann H. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test. Cancer Lett. 1977 Jan;2(3):139–145. doi: 10.1016/s0304-3835(77)80003-7. [DOI] [PubMed] [Google Scholar]
  26. Nakajima T., Chikamori M., Isojima K., Iwaguchi T. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients. Gan. 1977 Aug;68(4):449–457. [PubMed] [Google Scholar]
  27. Preece A. W., Light P. A. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Clin Exp Immunol. 1974 Dec;18(4):543–552. [PMC free article] [PubMed] [Google Scholar]
  28. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases. Br J Cancer. 1976 Jul;34(1):1–6. doi: 10.1038/bjc.1976.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation. Lancet. 1972 Sep 23;2(7778):627–629. doi: 10.1016/s0140-6736(72)93018-8. [DOI] [PubMed] [Google Scholar]
  31. Pritchard J. A., Sutherland W. H., Teasdale C., Whitehead R. H., Deeley T. J., Hughes L. E. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease. Ann Clin Res. 1978 Apr;10(2):71–74. [PubMed] [Google Scholar]
  32. Rahi A. H., Otiko G., Winder A. F. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours. Br J Ophthalmol. 1976 Aug;60(8):589–593. doi: 10.1136/bjo.60.8.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rawlins G. A., Wood J. M., Bagshawe K. D. Macrophage electrophoretic mobility (MEM) with myelin basic protein. Br J Cancer. 1976 Dec;34(6):613–618. doi: 10.1038/bjc.1976.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ritter J., Oehme J. Erafhrungen mid dem Elektrophorese-Mobilitäts-Test bei Kindern. Eine diagnostische Hilfe in der pädiatrischen Onkologie? Monatsschr Kinderheilkd. 1978 Sep;126(9):556–560. [PubMed] [Google Scholar]
  35. Shenton B. K., Jenssen H. L., Werner H., Field E. J. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests. J Immunol Methods. 1977;14(2):123–139. doi: 10.1016/0022-1759(77)90003-5. [DOI] [PubMed] [Google Scholar]
  36. Tautz C., Schneider W., Laier E., Brügmann G. Der Elektrophoretische-Mobilitäts-(EM) Test: Untersuchungsmethode zur Unterscheidung von malignen und nicht malignen Tumoren. Klin Wochenschr. 1978 Feb 15;56(4):175–185. doi: 10.1007/BF01705381. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES